CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II	2010-12-17	Registered
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II	2010-12-17	Registered
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III.	2010-12-17	Registered
Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors.	2010-12-17	Registered
1E10 anti-idiotype vaccine, metastatic colon, phase II.	2010-12-03	Registered
99mTc-marked 14F7 MaB in metastatic breast, phase II	2008-12-27	Registered
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT	20/10/2021	Registered
NeuroEPO in mild-moderate Alzheimer's disease	20/09/2022	Registered
NeuroEPO-Ataxia-Adults-Phase III	19/11/2020	Registered outdated
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM)	18/06/2021	Registered outdated
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders	18/06/2021	Registered outdated
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults	18/03/2021	Registered outdated
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial	17/10/2018	Registered
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors	17/02/2017	Registered
Her1 vaccine in metastatic colon and prostate cancer	16/08/2023	Registered
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients	15/12/2015	Registered
Vaxira as adjuvant treatment for non-small cell lung cancer	15/12/2015	Registered outdated
EC122 HER-1 Prostate Phase I	15/11/2016	Registered
CIMAvax-EGF vaccine Predictor Phase IV	14/12/2015	Registered outdated
NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer	12/10/2016	Registered

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY

About the RPCEC

Useful resources